[181]
Uncertainty in the Relation between Exposure to Magnetic Fields ...
From [www.annalsnyas.org] Last viewed: 07.09.2006
Brain metastases are an increasingly important cause of morbidity and mortality
among patients with metastatic breast cancer (MBC).This clinical situation
represents a therapeutic challenge for the treating physician and an emotionally
and physically debilitating experience for the patient.While significant advances
have been achieved in the treatment of MBC,more research is necessary to
determine appropriate protocols for early diagnosis,proper surveillance,and
effective treatments for MBC that has spread to the brain .
Brain metastases are the most common brain tumors seen in clinical practice
today,comprising well over half of all brain tumors.The annual incidence of brain
metastases in the United States is nearly 170,000 cases,compared with only
17,000 for primary brain tumors.
i
The risk of developing brain metastases varies
according to primary tumor type.Approximately 15 percent ...
[182]
The blood-brain barrier, cancer, cell phones, and microwave ...
From [ieeexplore.ieee.org] Last viewed: 07.09.2006
Abstract. The purpose of this study was to estimate the risk of
thyroid cancer induction attributable to brain radiation therapy
in adult and pediatric patients. An anthropomorphic phantom
was used to simulate treatment of brain tumors with two lateral
opposed fields. Thyroid dose was measured using thermo-
luminescent dosimeters. Phantom measurements were per-
formed for all possible field sizes that may be applied during
brain radiotherapy in adults and children. The dependence of
the thyroid dose on the distance from the irradiation field and
on the presence of beam modifiers in the primary beam was
investigated. All phantom exposures were generated with a
6 MV photon beam. Thyroid dose was found to vary from
9.6 to 89.4 cGy and from 8.0 to 194.0 cGy depending upon
the field size used and the thyroid location in respect to the
field edge for adults and children respectively. The excess
relative ...
[183]
Health effects - the blood-brain barrier, cancer, cell phones, and ...
From [ieeexplore.ieee.org] Last viewed: 07.09.2006
Abstract. The purpose of this study was to estimate the risk of
thyroid cancer induction attributable to brain radiation therapy
in adult and pediatric patients. An anthropomorphic phantom
was used to simulate treatment of brain tumors with two lateral
opposed fields. Thyroid dose was measured using thermo-
luminescent dosimeters. Phantom measurements were per-
formed for all possible field sizes that may be applied during
brain radiotherapy in adults and children. The dependence of
the thyroid dose on the distance from the irradiation field and
on the presence of beam modifiers in the primary beam was
investigated. All phantom exposures were generated with a
6 MV photon beam. Thyroid dose was found to vary from
9.6 to 89.4 cGy and from 8.0 to 194.0 cGy depending upon
the field size used and the thyroid location in respect to the
field edge for adults and children respectively. The excess
relative ...
[184]
Cancer cell invasion of brain tissue: guided by a prepattern?
[21,7 KB]
From [taylorandfrancis.metapress.com] Last viewed: 07.09.2006
Cancer Incidence by Proportion
Indigenous Population in
Queensland
Cancer of the Brain Meninges
and other central nervous system
0
3
6
9
12
15
0
3
6
9
12
15
Male
Female
Rate per 100,000 population
Rate per 100,000 population
Avg No.
Avg No.
per Year
per Year
Incidence of Cancer of the Brain Meninges and other central nervous system,
by Indigenous Proportion and Sex, Queensland,
Five Year Average, 1998 to 2002
8.7
131
6.3
102
<5% Indigenous
Proportion
Indigenous
Population
6.7
12
4.8
8
At least 5% Indigenous
Note:
Rates are age standardised to the Australian population as at 30 June 2001. Numbers and rates are averaged
over five years, and based on place of usual residence at time ...
[185]
Long-term survival after excision of a solitary esophageal cancer ...
From [jtcs.ctsnetjournals.org] Last viewed: 07.09.2006
TimePeriod
Obs
Exp
SIR
Obs
Exp
SIR
Obs
Exp
SIR
1982 - 1988
33
30.1
110
75 -- 154
13
13.5
96
51 -- 164
20
16.6
121
1989 - 1995
33
29.6
111
77 -- 156
15
14.1
107
60 -- 176
18
15.6
116
1996 - 2001
26
20.0
130
85 -- 190
12
10.4
116
60 -- 202
14
9.6
145
Note: SIRs are calculated based on the exact number of expected cases.
Expected number of cases presented are rounded to the nearest tenth.
SIRs and 95% CI are not calculated when observed number of cases < 5.
Obs = Observed number of cases
95% CI = 95% Confidence Interval
Exp = Expected number of cases
NC = Not calculated
SIR = Standardized Incidence Ratio
* = Statistical significance
Data Source: Massachusetts ...
[186]
Targeting HER2 in Brain Metastases from Breast Cancer
[15,8 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
1
Brain Cancer and Magnetic Resonance Spectroscopy
Jeffry R. Alger, PhD
Department of Radiological Sciences
Jonsson Comprehensive Cancer Center
Brain Research Institute
Ahmanson-Lovelace Brain Mapping Center
University of California, Los Angeles
I. Introduction
II. MRS fundamentals in relation to brain cancer
III. The MRS appearance of brain tumors
IV. Clinical uses of MRS for brain tumor management
V. Summary
VI. Glossary
VII. Bibliography
I. Introduction
Brain cancer has been studied with Magnetic Resonance Spectroscopy (MRS) for
approximately the past ten years. This research is now leading to the regular use of MRS for the
routine clinical evaluation of brain cancer patients. This article will summarize the present state of
knowledge related to MRS and brain cancer and illustrate likely future areas of development and
application.
...
[187]
Expression of Cancer Testis Genes in Human Brain Tumors
[97,7 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
1
Brain Cancer and Magnetic Resonance Spectroscopy
Jeffry R. Alger, PhD
Department of Radiological Sciences
Jonsson Comprehensive Cancer Center
Brain Research Institute
Ahmanson-Lovelace Brain Mapping Center
University of California, Los Angeles
I. Introduction
II. MRS fundamentals in relation to brain cancer
III. The MRS appearance of brain tumors
IV. Clinical uses of MRS for brain tumor management
V. Summary
VI. Glossary
VII. Bibliography
I. Introduction
Brain cancer has been studied with Magnetic Resonance Spectroscopy (MRS) for
approximately the past ten years. This research is now leading to the regular use of MRS for the
routine clinical evaluation of brain cancer patients. This article will summarize the present state of
knowledge related to MRS and brain cancer and illustrate likely future areas of development and
application.
...
[188]
Metabolic and Hemodynamic Evaluation of Brain Metastases from ...
[1225,9 KB]
From [clincancerres.aacrjournals.org] Last viewed: 07.09.2006
1
Brain Cancer and Magnetic Resonance Spectroscopy
Jeffry R. Alger, PhD
Department of Radiological Sciences
Jonsson Comprehensive Cancer Center
Brain Research Institute
Ahmanson-Lovelace Brain Mapping Center
University of California, Los Angeles
I. Introduction
II. MRS fundamentals in relation to brain cancer
III. The MRS appearance of brain tumors
IV. Clinical uses of MRS for brain tumor management
V. Summary
VI. Glossary
VII. Bibliography
I. Introduction
Brain cancer has been studied with Magnetic Resonance Spectroscopy (MRS) for
approximately the past ten years. This research is now leading to the regular use of MRS for the
routine clinical evaluation of brain cancer patients. This article will summarize the present state of
knowledge related to MRS and brain cancer and illustrate likely future areas of development and
application.
...
[189]
Identification of candidate cancer-causing genes in mouse brain ...
[262,9 KB]
From [www.pnas.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[190]
Brain-associated Small-cell Lung Cancer Antigen (BASCA) Is ...
[1313,6 KB]
From [www.jhc.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[191]
Overexpression of ADAM9 in Non-Small Cell Lung Cancer Correlates ...
[687,5 KB]
From [cancerres.aacrjournals.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[192]
Identification of a Cancer Stem Cell in Human Brain Tumors
[675,3 KB]
From [cancerres.aacrjournals.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[193]
Detection of Brain Metastasis in Potentially Operable Non-small ...
[703,0 KB]
From [www.chestjournal.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[194]
Surgical Management of Non-small Cell Lung Cancer With Synchronous ...
[740,5 KB]
From [www.chestjournal.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[195]
Evaluation of the treatment of non-small cell lung cancer with brain
From [ejcts.ctsnetjournals.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[196]
Prognosis of patients with non-small cell lung cancer with ...
From [ejcts.ctsnetjournals.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[197]
Lung Cancer and Its Operable Brain Metastasis: Survival Rate and ...
From [ats.ctsnetjournals.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[198]
Risk and patterns of brain metastases in colorectal cancer
[17,9 KB]
From [pepublishing.metapress.com] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[199]
Cis-diamminedichloroplatinum (CDDP) therapy for brain metastasis ...
[14,6 KB]
From [heldref.metapress.com] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[200]
Epithelial Ovarian Cancer Metastasizing to the Brain: A Late ...
[119,1 KB]
From [intl.jco.org] Last viewed: 07.09.2006
National Cancer Institute
SEER Program
26
C
omparisons of the incidence rates for
cancers occurring in the brain and elsewhere in
the nervous system among different populations
are often difficult because of different practices
regarding the inclusion or exclusion of benign
tumors. Only brain and other nervous system cancers
classified as malignant, however, are included in the SEER
incidence data. Malignant neoplasms of the brain and other
nervous system are relatively rare, occur
more frequently among men than among
women; and most racial/ethnic groups have
a male-to-female ratio around 1.4. Children
and adults have different distributions of
subtypes of malignancies in the central
nervous system.
There were too few cases to calculate
meaningful incidence rates for Japanese
women and for men or women in the Alaska
Native, American ...
[201]
Brain Cancer
From [www.thaigraphic.com] Last viewed: 07.09.2006
Asian Pacific Journal of Cancer Prevention, Vol 2, 2001
143
Prophylaxis of Cancer Using Brain Properties
COMMENTARY
Introduction
The main and basic task of medicine is complete and
qualitative provision of human health. Unfortunately,
however, contemporary medicine isn’table to guarantee this.
Nowadays in medicine the most developed directions are in
surgery, epidemiology, success also reached by diagnosis
of diseases with alterations in organ structure and form,
when defects of tissue and cancer are observed.
Therapeutical directions are only weakly developed. The
development of science revealing the reasons for many
chronic diseases is also weak. Cancers and other tumours
are treated without revelations of their reasons. That’s why
their treatment has an empirical character. There isn’t a
theory which has scientific basis and is able to explain real
...
[202]
Stakeholder Opinions: Primary Brain Cancer
From [www.datamonitor.com] Last viewed: 07.09.2006
www.datamonitor.com/healthcare
Stakeholder Opinions:
Primary Brain Cancer
Temozolomide Turns Heads
A Datamonitor Report
Published: Jul-05
Product Code: DMHC2102
Use this Report to
Understand the limitations of current
therapy available to glioma patients
Providing you with:
• Overview of disease including
epidemiology, biology of glioma and
prognostic variables
• Current treatment options and clinical
controversies, including comments from
opinion leaders
• Key recommendations in the areas of
greatest unmet need in glioblastoma
patients
• Profiles of agents in late stage
development, including opinions from
glioma specialists
Page 2
Stakeholder Opinions: Primary Brain Cancer – Temozolomide Turns Heads
DMHC2102
The incidence of glioblastoma is increasing. ...
[203]
Comparison of Brain Cancer Statistics for Caucasains in ...
From [www.personal.psu.edu] Last viewed: 07.09.2006
+526 to +137
+136 to +63
+62 to -11
-12 to -67
250 - 1838
107 - 249
35 - 106
4 - 34
+2.9 to +5.2
+1.8 to +2.8
+0.6 to +1.7
-2.6 to +0.5
Mean
106
Mean
+62
Mean
+1.7
Deaths caused by Brain Cancer in 1950 - '54
Deaths caused by Brain Cancer in 1990 - '94
Brain Cancer Deaths in 1950 - '54 compared to 1990 - '94
Mortality Rate of Brain Cancer in 1950 - '54 to 1990 - '94
Higher in
1990 - '94
Higher in
1950 - '54
Higher in
1990 - '94
Higher in
1950 - '54
Mean
37
Legend
Legend
87 - 527
38 - 86
13 - 37
2 - 12
Legend
Legend
Number of Deaths
Number of Deaths
Change in Deaths
Change in Rate
Std. Dev.
Std. Dev.
Std. Dev.
Std. Dev.
50
Miles
50
Miles
50
...
[204]
A221( ? )- Brain cancer tissues Specifications: • No. of cases ...
[361,3 KB]
From [search.cosmobio.co.jp] Last viewed: 06.07.2006
Web Immagini Gruppi Directory News altro »
Ricerca avanzata Preferenze
Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL
Web
La ricerca di - cache:udLsunwj640J:search.cosmobio.co.jp/cosmo_search_p/search_gate2/docs/PET_/CBA221II.20060626.pdf brain cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti:
Assicurarsi che tutte le parole siano state digitate correttamente.
Provare con parole chiave diverse.
Provare con parole chiave più generiche.
Provare con ...
[205]
A221( ? ) Brain cancer tissues: grade ? ~ ? Specifications ...
[329,3 KB]
From [search.cosmobio.co.jp] Last viewed: 06.07.2006
For research use only
A221( ? ) Brain cancer tissues: grade ? ~ ?
(formalin fixed)
Specifications:
• No. of cases: 30
• Tissue type: Brain cancer tissues: grade ?~?
• No. of spots: 2 spots from each cancer case (60 spots)
2 non-neoplastic spots (2 spots)
•Total spots: 62
• Corresponding normal tissues with cancers: Yes
• Diameter: 1. 0 mm
Documents :
• Product specification: layout, summary of tissue spots
• H&E stained images
• Detailed pathological information
Layout:
1
2
3
4
5
6
7
8
A
B
C
D
E
F
G
H
I
WHO and St.Anne/Mato grading system
WHO designation
St.Anne/Mayo designation
:
III
Anaplastic astrocytoma
Astrocytoma grade 3
:
IV
Glioblastoma multiforme
Astrocytoma grade 4
...
[206]
Specifications: • No. of cases: 30 • Tissue type: Brain cancer ...
[233,5 KB]
From [search.cosmobio.co.jp] Last viewed: 06.07.2006
A221(I) : Brain cancer tissues: Glioblastoma
(formalin fixed)
For research use only
Specifications:
• No. of cases: 30
• Tissue type: Brain cancer tissues: Glioblastoma
• No. of spots: 2 spots from each cancer case (60 spots)
2 non-neoplastic spots (2 spots)
• Total spots: 62
• Corresponding normal tissues with cancers: Yes
• Diameter: 1. 0 mm
Documents :
• Product specification: layout, summary of tissue spots
• H&E stained images
• Detailed pathological information
Layout:
Page 2
Summary of tissue spots
A221(I) : Brain cancer tissues: Glioblastoma
(formalin fixed)
For research use only
No.
Sex
Age
Key Word
1
1, 2
f
68
glioblastoma
2
3, 4
f
67
glioblastoma
3
5, 6
m
54
...
[207]
Managing Brain Metastases in Patients with Advanced Breast Cancer
[2136,1 KB]
From [www.cinnfoundation.org] Last viewed: 06.07.2006
Brain metastases are an increasingly important cause of morbidity and mortality
among patients with metastatic breast cancer (MBC).This clinical situation
represents a therapeutic challenge for the treating physician and an emotionally
and physically debilitating experience for the patient.While significant advances
have been achieved in the treatment of MBC,more research is necessary to
determine appropriate protocols for early diagnosis,proper surveillance,and
effective treatments for MBC that has spread to the brain .
Brain metastases are the most common brain tumors seen in clinical practice
today,comprising well over half of all brain tumors.The annual incidence of brain
metastases in the United States is nearly 170,000 cases,compared with only
17,000 for primary brain tumors.
i
The risk of developing brain metastases varies
according to primary tumor type.Approximately 15 percent ...
[208]
MDS Nordion Signs Agreement with Bradmer Pharmaceuticals Inc. for ...
[92,5 KB]
From [www.mds.nordion.com] Last viewed: 06.07.2006
MDS Nordion Signs Agreement with Bradmer Pharmaceuticals Inc.
for Novel Brain Cancer Therapeutic
Ottawa, Canada, April 19, 2006 – MDS Nordion, the world’s leading provider of medical isotopes and
radiopharmaceutical services, has signed a three-year contract with Bradmer Pharmaceuticals Inc. for the development
and clinical trial supply of Neuradiab, a monoclonal antibody conjugated to iodine-131 used to treat glioblastoma
multiforme (GBM), the most common and deadly form of brain cancer .
“MDS Nordion is thrilled to team up with Bradmer Pharmaceuticals in their fight against this terrible disease,” said
Steve West, President of MDS Nordion. “We are pleased that our world-class cGMP facilities, wealth of expertise and
dedication to bringing products to market quickly will contribute to Neuradiab’s development and its potential
success.”
According to the World Health Organization, GBM is usually fatal ...
[209]
Childhood Brain Cancer and Potential Residential Exposure to ...
[12,1 KB]
From [epa.gov] Last viewed: 06.07.2006
Childhood Brain Cancer and Potential Residential Exposure to Toxics Release Inventory
Chemicals during Pregnancy
Authors: Hannah Choi
1
, Youn Shim
2
, Wendy Kaye
2
, P. Barry Ryan
1
1
Department of Environmental and Occupational Health, Rollins School of Pubic Health, Emory
University
2
Division of Health Studies, Agency for Toxic Substances and Disease Registry (ATSDR)
Keywords: children’s health, brain cancer , toxics release inventory, air emissions, pregnancy
Background: We examined whether mothers of children with brain cancer had greater potential
residential exposure to Toxics Release Inventory (TRI) chemicals during pregnancy than
mothers of children without any cancer (controls).
Methods: Cases included 382 children born after 1987 and diagnosed with first primary brain
cancer before age ten ...
[210]
INTERPHONE: Mobile phone brain cancer study in Germany
[169,4 KB]
From [www.mmfai.org] Last viewed: 06.07.2006
The GSM Association (GSMA) is the global trade association that exists to promote, protect and enhance the interests of GSM mobile operators
throughout the world. www.gsmworld.com
The MMF is an international association of wireless communications manufacturers established to support scientific research in relation to
mobile telephony and health www.mmfai.info
INTERPHONE: Mobile phone brain cancer study in Germany
Adding to a growing list of completed national INTERPHONE projects, medical researchers
in Germany have published their epidemiological study on the association of mobile and
cordless phone use with two types of brain cancer , glioma
*
and meningioma
†
. The researchers
were mostly medical statisticians and epidemiologists from various research bodies in
Germany and were led by Dr Joachim Schüz. The study was funded by contributions from the ...
Found 657 documents
Page 7 of 22 Pages:
<< < 2 3 4 5 6 7 8 9 10 11 12 > >>
cancers
homepage
last week